Continuation of hormone replacement therapy in Slovenia: A prospective, randomized, controlled trial-1-year follow-up

Maturitas

Volumn 54, Issue 2, 2006, Pages 110-118

  Franić, Damir ^a   Verdenik, Ivan ^b   Meden Vrtovec, Helena ^b   Švab, Igor ^c  

^a Outpatient Clinic of Obstetrics and Gynecology   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Compliance; Hormone therapy; Patient education; Perimenopausal women

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEALTH EDUCATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SLOVENIA; SURVIVAL;

ADULT; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PROSPECTIVE STUDIES; SLOVENIA;

EID: 33748066985     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.09.002     Document Type: Article

References (32)

1. Shmuely Y., Berlin J.A., Knauss J., and Lydick E. Compliance with oral HRT in postmenopausal women in clinical trials-meta analysis. Maturitas 46 (2003) 33-44
2. Haskell S.G. After the Women's Health Initiative: postmenopausal women's experiences with discontinuing estrogen replacement therapy. J Women Health 13 4 (2004) 438-442
3. Fistonić I., Ciglar S., Fistonić M., and Škegro I. Menopause in Croatia. Socio-demographic characteristics, women's attitudes and source of information, compliance with HRT. Maturitas 47 (2004) 91-98
4. Corrado F., D'Anna R., Caputo F., Cannata M.L., Zoccali M.G., and Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 118 (2005) 225-228
5. Lawton B., Rose S., McLeod D., and Dowell A. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. Br Med J 327 (2003) 845-846
6. Barbieri RL, Lobo RA, Walsh BW, Santoro NF. Improving quality of life during menopause: the role for hormone replacement therapy. In: APGO Educational Series on Women's Health Issues; 2002. p. 4-7.
7. Holm S. What is wrong with compliance?. J Med Ethics 19 (1993) 108-110
8. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 56 (1995) 4-8
9. Anon Editor's choice. Compliance-a broken concept. Br Med J 1997;314:1.
10. Reynolds R.F., Obermayer C.M., Walker A.M., and Guilbert D. The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy. Maturitas 43 (2002) 183-194
11. Utian W.H. If drugs can prevent disease, why is continuance is so poor?. Menopause Manage 13 5 (2004) 9-10
12. Grady D., Rubin S.M., Petitti D.B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 (1992) 1016-1037
13. Col N.F., Pauker S.G., Goldberg R.J., et al. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med 159 (1999) 1458-1466
14. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., and Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133 (2000) 933-941
15. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
16. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 288 (2002) 49-57
17. Herrington D.M., Reboussin D.M., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 343 (2000) 522-529
18. Rossow J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
19. Hoibraaten E., Qvigstad E., Arnesen H., Larsen S., Wickstrom E., and Sandset P.M. Increased risk of recurrent venous thromboembolism during hormone replacement therapy: results of the randomized, double-blind, placebo-controlled estrogen and in venous thromboembolism trial (EVTET). Thromb Haemost 84 (2000) 961-967
20. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., and Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345 (2001) 1243-1249
21. Beral V., Banks E., and Reeves G. Evidence from randomized trials on the long term effects of hormone replacement therapy. Lancet 360 (2002) 942-944
22. Franić D., and Fürst J. The use of hormones during the perimenopausal period in Slovenia. Zdrav Vestn 72 (2003) II-3-II-8
23. Slovenian health insurance data base; 2005.
24. Fleiss J.L. The design and analysis of clinical experiments (1985), John Wiley and Sons, New York
25. Buist D.S., Newton K.M., Miglioretti D.L., et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 104 (2004) 1042-1050
26. Strothmann A., and Schneider H.P. Patient perception and information. Gynecol Forum 9 (2004) 20-22
27. Hammar M., Brynhildsen J., Dabrosin L., et al. Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 25 (1996) 193-199
28. Li C., Samsioe G., Lidfelt J., Nerbrand C., and Agardh C.D. Important factors for use of hormone replacement therapy: a population based study of Swedish women. The Women's Health in the Lund Area (WHILA) study. Menopause 7 (2000) 273-281
29. Grady D. Postmenopausal hormones-therapy for symptoms only. N Engl J Med 348 19 (2003) 1835-1837
30. Pinter B., Meden-Vrtovec H., Maček M., Verdenik I., et al. Menopavza v Sloveniji: Značilnosti žensk in pojavnost premenopavznih simptomov [Menopause in Slovenia: women's characteristics and the frequency of perimenopausal symptoms]. Zdrav Vestn 72 (2003) II-9-II-12
31. Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 20 (1994) 91-99
32. Advisory Panel. Position statement estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of the North American Menopause Society. Menopause 2003;10:6-12.